1. Home
  2. CYTK vs AL Comparison

CYTK vs AL Comparison

Compare CYTK & AL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • AL
  • Stock Information
  • Founded
  • CYTK 1997
  • AL 2010
  • Country
  • CYTK United States
  • AL United States
  • Employees
  • CYTK N/A
  • AL N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • AL Diversified Commercial Services
  • Sector
  • CYTK Health Care
  • AL Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • AL Nasdaq
  • Market Cap
  • CYTK 5.6B
  • AL 4.7B
  • IPO Year
  • CYTK 2004
  • AL 2011
  • Fundamental
  • Price
  • CYTK $32.43
  • AL $56.48
  • Analyst Decision
  • CYTK Buy
  • AL Buy
  • Analyst Count
  • CYTK 14
  • AL 5
  • Target Price
  • CYTK $70.92
  • AL $58.80
  • AVG Volume (30 Days)
  • CYTK 1.3M
  • AL 810.2K
  • Earning Date
  • CYTK 08-07-2025
  • AL 07-31-2025
  • Dividend Yield
  • CYTK N/A
  • AL 1.56%
  • EPS Growth
  • CYTK N/A
  • AL 15.59
  • EPS
  • CYTK N/A
  • AL 5.72
  • Revenue
  • CYTK $19,218,000.00
  • AL $2,808,629,000.00
  • Revenue This Year
  • CYTK $18.02
  • AL $10.00
  • Revenue Next Year
  • CYTK $737.32
  • AL $7.18
  • P/E Ratio
  • CYTK N/A
  • AL $9.87
  • Revenue Growth
  • CYTK 412.21
  • AL 3.56
  • 52 Week Low
  • CYTK $29.31
  • AL $38.25
  • 52 Week High
  • CYTK $61.38
  • AL $59.27
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 46.32
  • AL 53.94
  • Support Level
  • CYTK $32.02
  • AL $56.09
  • Resistance Level
  • CYTK $34.72
  • AL $58.27
  • Average True Range (ATR)
  • CYTK 1.30
  • AL 0.95
  • MACD
  • CYTK 0.26
  • AL -0.50
  • Stochastic Oscillator
  • CYTK 45.08
  • AL 16.81

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AL Air Lease Corporation

Air Lease Corp is an aircraft leasing company based in the United States. It is engaged in purchasing commercial jet aircrafts directly from aircraft manufacturers and leasing those aircraft to airlines throughout the world to generate attractive returns on equity. The company also sells aircraft from its fleet to third parties, including other leasing companies, financial services companies, airlines, and other investors, and offers fleet management services to investors and owners of aircraft portfolios for a management fee. Geographically, it derives a majority of its revenue from the Asia-Pacific region and the rest from Europe, Middle East and Africa, Central America, South America, Mexico, the United States, and Canada.

Share on Social Networks: